ES2070488T5 - Procedimiento para la diagnosis de enfermedades tumorales. - Google Patents

Procedimiento para la diagnosis de enfermedades tumorales.

Info

Publication number
ES2070488T5
ES2070488T5 ES91902191T ES91902191T ES2070488T5 ES 2070488 T5 ES2070488 T5 ES 2070488T5 ES 91902191 T ES91902191 T ES 91902191T ES 91902191 T ES91902191 T ES 91902191T ES 2070488 T5 ES2070488 T5 ES 2070488T5
Authority
ES
Spain
Prior art keywords
pct
receptors
date jul
sample
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91902191T
Other languages
English (en)
Other versions
ES2070488T3 (es
Inventor
Heinz Bodenmuller
Andreas Dessauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6396458&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2070488(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Application granted granted Critical
Publication of ES2070488T3 publication Critical patent/ES2070488T3/es
Publication of ES2070488T5 publication Critical patent/ES2070488T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Abstract

PARA DETECTAR ENFERMEDADES MALIGNAS SE INCUBA UNA MUESTRA DE UN LIQUIDO DEL CUERPO CON DOS RECEPTORES, R SUB 1 Y R SUB 2, POR LO MENOS Y SE PRODUCE UNA VARIACION EN LA SEÑAL ENLAZANDO POR LO MENOS LOS RECEPTORES R SUB 1 Y R SUB 2 A UNA SUSTANCIA QUE VA A SER DETECTADA EN LA SOLUCION DE MUESTRA. UNO DE LOS DOS RECEPTORES CONTIENE UN ANTICUERPO MONOCLONAL QUE ENLAZA LA SECUENCIA AMINOACIDA (291 A 335) DE CITOCESATINA (19) Y EL OTRO RECEPTOR CONTIENE UN ANTICUERPO MONOCLONAL QUE ENLAZA LA SECUENCIA AMINOACIDA (346 A 367) DE CITOCERATINA (19) Y DETERMINA LA VARIACION DE LA SEÑAL DEBIDA AL ENLACE.
ES91902191T 1989-12-27 1990-12-27 Procedimiento para la diagnosis de enfermedades tumorales. Expired - Lifetime ES2070488T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3942999A DE3942999C2 (de) 1989-12-27 1989-12-27 Verfahren zum Nachweis von malignen Erkrankungen

Publications (2)

Publication Number Publication Date
ES2070488T3 ES2070488T3 (es) 1995-06-01
ES2070488T5 true ES2070488T5 (es) 2002-07-01

Family

ID=6396458

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91902191T Expired - Lifetime ES2070488T5 (es) 1989-12-27 1990-12-27 Procedimiento para la diagnosis de enfermedades tumorales.

Country Status (9)

Country Link
US (1) US5288614A (es)
EP (1) EP0460190B2 (es)
JP (1) JPH082919B2 (es)
AT (1) ATE120550T1 (es)
CA (1) CA2046888A1 (es)
DE (2) DE3942999C2 (es)
DK (1) DK0460190T3 (es)
ES (1) ES2070488T5 (es)
WO (1) WO1991010139A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4208422A1 (de) * 1992-03-16 1993-09-30 Boehringer Mannheim Gmbh Verfahren zum Nachweis von Mikrometastasen ekto- oder entodermaler Tumoren
US5547928A (en) * 1993-12-17 1996-08-20 Matritech, Inc. Methods and compositions for the detection of colon cancers
US6207380B1 (en) 1997-09-15 2001-03-27 Abbott Laboratories Reagents and methods useful for detecting diseases of the urinary tract
DE19855819C2 (de) * 1998-12-03 2001-02-15 Roche Diagnostics Gmbh Stabilisierung von Cytokeratin enthaltenden Kalibratoren
US8986944B2 (en) 2001-10-11 2015-03-24 Aviva Biosciences Corporation Methods and compositions for separating rare cells from fluid samples
US8980568B2 (en) * 2001-10-11 2015-03-17 Aviva Biosciences Corporation Methods and compositions for detecting non-hematopoietic cells from a blood sample
US20070134742A1 (en) * 2003-10-30 2007-06-14 Koichi Nakano Diagnostic reagent for uterine adenocarcinoma and method of detecting adenocarcinoma cells
WO2007076439A2 (en) * 2005-12-22 2007-07-05 Abbott Laboratories Methods and marker combinations for screening for predisposition to lung cancer
EP2041299A4 (en) * 2006-07-14 2010-01-13 Aviva Biosciences Corp METHOD AND COMPOSITIONS FOR DETECTION OF RARE CELLS FROM A BIOLOGICAL SAMPLE
WO2008029251A2 (en) * 2006-09-07 2008-03-13 Universitatsklinikum Hamburg-Eppendorf Method for the detection of cancerous epithelial cells using released cytokeratins as markers for said cells
US9255142B2 (en) * 2010-09-09 2016-02-09 Beijing Cotimes Biotech Co., Ltd. Blood markers for diagnosing epithelium derived cancers and monoclonal antibodies thereof
BR112014032728A2 (pt) 2012-06-27 2017-11-28 Berg Llc uso de marcadores no diagnóstico e tratamento de câncer de próstata
NZ721962A (en) * 2014-02-05 2022-10-28 Fujirebio Diagnostics Ab Composition and method for detecting malignant neoplastic disease
SG10202012249YA (en) 2014-12-08 2021-01-28 Berg Llc Use of markers including filamin a in the diagnosis and treatment of prostate cancer
JP6637290B2 (ja) * 2015-11-05 2020-01-29 武 永安 Ｃｋ１９に特異的なモノクローナル抗体およびこれを産生するハイブリドーマ、癌の検出キット、癌の検出方法および癌の転移の判定方法
US10301057B2 (en) 2016-07-11 2019-05-28 Calibre Closures Llc Dispensing container with internal squeeze limiting member
CN113061184B (zh) * 2021-04-25 2022-07-01 福州迈新生物技术开发有限公司 抗ck7蛋白单克隆抗体及其细胞株、制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2723203B2 (ja) * 1984-01-06 1998-03-09 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア サイトケラチン腫瘍マーカー及びそれらの検出のためのアッセイ
US4727021A (en) * 1984-06-01 1988-02-23 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies to cytokeratin
DE3815932A1 (de) * 1988-01-26 1989-08-03 Progen Biotechnik Gmbh Verfahren zur identifizierung des ursprungs einer zellgewebsprobe
DE3640412A1 (de) * 1986-11-26 1988-06-09 Boehringer Mannheim Gmbh Verfahren zur bestimmung einer spezifisch bindefaehigen substanz

Also Published As

Publication number Publication date
JPH082919B2 (ja) 1996-01-17
EP0460190B1 (de) 1995-03-29
ATE120550T1 (de) 1995-04-15
ES2070488T3 (es) 1995-06-01
DE3942999C2 (de) 1997-12-18
DE59008810D1 (de) 1995-05-04
DK0460190T3 (da) 1995-08-28
US5288614A (en) 1994-02-22
DE3942999A1 (de) 1991-07-04
EP0460190A1 (de) 1991-12-11
EP0460190B2 (de) 2001-11-28
CA2046888A1 (en) 1991-06-28
WO1991010139A1 (de) 1991-07-11
JPH04504063A (ja) 1992-07-23

Similar Documents

Publication Publication Date Title
ES2070488T5 (es) Procedimiento para la diagnosis de enfermedades tumorales.
DE3887675T2 (de) Antikörper.
Ehrlich et al. Cooperative immunoassays: ultrasensitive assays with mixed monoclonal antibodies
ES512498A0 (es) "metodo y su correspondiente aparato para el ensayo de anticuerpos con respecto a antigenos solubles".
ES2089048T3 (es) Procedimiento para la deteccion de proteinas que contienen tirosina fosforilada.
NO163920C (no) Fremgangsmaate for bestemmelse av pivka-ii i fysiologiske proever.
DE69018968D1 (de) BLUTGERINNUNGSFAKTOR BETA XIIa MONOKLONALE ANTIKÖRPER UND IMMUNANALYSE.
ATE188551T1 (de) Feststellung von antikörperproduktion
ES2026146T3 (es) Procedimiento para la preparacion de un medio de incubacion para ensayos inmunometricos en fase solida.
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
KR870002453A (ko) 프로좀 단백질에 대한 단일항체의 제조방법 및 그를 이용한 프로좀과 관련된 현상의 검출 및 질병의 진단법
ES8705232A1 (es) Un metodo para preparar un anticuerpo monoclonal destinado autilizarse como auxiliar de diagnostico para detectar cancerde pulmon
FI86255B (fi) Monoklonal antiurokinase-antikropp, den innehaollande matris och biokemiska testpackningar, i vilka den anvaendes.
ES2033834T3 (es) Un metodo para determinar alteraciones de la gestion.
FI943921A (fi) Vapaan trypsinogeeni-2:n määritys
WO1990008956A1 (fr) Detection d'activateur de facteur tissulaire humain
KR860007545A (ko) 인체 프로릴 4-히드록시라아제의 정량 방법
Davies et al. Demonstration of antiglobulin activity in the synovial membrane of patients with rheumatoid arthritis and ankylosing spondylitis after pepsin treatment: real or artefact?
KR890702037A (ko) 간장암 질환의 진단법
ES8405155A1 (es) Procedimiento de inmunoanalisis para determinar etosuximida en una muestra de analisis.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 460190

Country of ref document: ES